Gentell Executive and Leadership Team

Darryl D'Souza, the Chief Financial Officer at Gentell, manages the fiscal health and capital allocation strategies for the medical manufacturing operations. D'Souza oversees financial reporting, budgeting, and long-term investment planning to sustain the production of barrier creams and sanitizing solutions. By analyzing market trends in the wound care sector, the Chief Financial Officer optimizes cost structures for raw material procurement and distribution logistics. Darryl D'Souza collaborates with executive leadership to evaluate the profitability of new product bundles and clinical offerings. This leadership role involves maintaining rigorous compliance standards while driving revenue growth across diverse healthcare channels. Through precise financial modeling, the Chief Financial Officer supports the expansion of the company's footprint in nursing homes and clinical facilities. Ultimately, D'Souza secures the necessary capital to fuel innovation in advanced dressing technologies and maintains the overall economic stability of the enterprise.

Roberto Schahin, the President, Gentell (Brazil) at Gentell, directs all commercial activities and market penetration strategies within the South American region. Schahin oversees the localization of wound care and skin protection product lines to meet specific regulatory and clinical requirements in Brazil. By building relationships with local hospitals and health agencies, the President, Gentell (Brazil) expands the reach of the company's hydrocolloid and transparent dressing portfolios. Roberto Schahin manages regional sales teams and distribution networks to ensure consistent product availability for healthcare providers. This leadership role involves adapting global manufacturing standards to local market nuances while driving regional revenue targets. Through strategic partnerships with medical distributors, the President, Gentell (Brazil) strengthens the brand presence in emerging markets. Ultimately, Schahin ensures that the company's commitment to high-quality patient care remains consistent across all South American operations.

Michael Lebovics, the President at Gentell, executes the overarching corporate strategy and oversees the manufacturing excellence of the company's wound care and skincare product lines. Lebovics directs the operational focus toward delivering high-performance dressings and sanitizers to hospitals and nursing homes. By fostering innovation in product development, the President ensures that the company maintains a competitive edge in the medical supply industry. Michael Lebovics coordinates with department heads to streamline production processes and enhance the efficacy of collagen and alginate dressings. This leadership role involves setting the vision for market expansion and ensuring that all business units align with the core mission of improving patient outcomes. Through the management of key stakeholder relationships, the President drives sustainable growth and operational efficiency. Ultimately, Lebovics maintains the company's reputation as a trusted provider of essential medical supplies across the healthcare continuum.

Brian Schorn, the President at Gentell, manages the strategic execution of business development and customer engagement initiatives for the company's diverse medical product portfolio. Schorn oversees the sales and marketing functions, ensuring that hospitals and home health agencies receive tailored solutions for wound care and odor elimination. By identifying new market opportunities, the President drives the adoption of advanced barrier creams and specialized dressings. Brian Schorn collaborates with the clinical team to demonstrate the value of the company's product bundles to healthcare administrators. This leadership role involves refining the go-to-market strategy to increase market share in the competitive medical manufacturing landscape. Through the oversight of regional sales performance, the President ensures that the company meets its growth objectives while maintaining high service standards. Ultimately, Schorn strengthens the company's position as a primary partner for healthcare facilities seeking reliable and effective skin protection solutions.

Glenn Thompson, the Chief Information Officer at Gentell, directs the digital infrastructure supporting the manufacturing and distribution of advanced wound care products. Thompson oversees the integration of data systems across hospitals and home health agencies to ensure seamless supply chain visibility. By architecting secure cloud environments, the Chief Information Officer protects sensitive medical data while optimizing internal workflows for the entire organization. Glenn Thompson drives the implementation of enterprise resource planning tools that track inventory levels for hydrogel, collagen, and foam dressings. This leadership role involves aligning technological capabilities with the evolving needs of the medical supply industry. Through the deployment of robust cybersecurity protocols, the Chief Information Officer mitigates operational risks. Ultimately, Thompson ensures that digital platforms remain scalable to support the expanding market reach of the company across North American healthcare networks.